Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-01-21 @ 5:51 PM
Study NCT ID:
NCT00910858
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2009-05-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes
Sponsor:
Organization: